Keystone Wealth Services’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,692
Closed -$209K 258
2024
Q2
$209K Buy
1,692
+97
+6% +$12.5K 0.07% 222
2024
Q1
$210K Sell
1,595
-2,637
-62% -$325K 0.07% 211
2023
Q4
$461K Sell
4,232
-177
-4% -$18.4K 0.16% 126
2023
Q3
$454K Buy
4,409
+63
+1% +$6.79K 0.17% 125
2023
Q2
$501K Buy
4,346
+2
+0% +$227 0.19% 117
2023
Q1
$462K Buy
4,344
+17
+0.4% +$1.83K 0.19% 120
2022
Q4
$480K Buy
4,327
+536
+14% +$54.8K 0.21% 106
2022
Q3
$326K Buy
3,791
+77
+2% +$6.87K 0.15% 113
2022
Q2
$339K Buy
3,714
+138
+4% +$12.2K 0.15% 113
2022
Q1
$293K Buy
3,576
+2
+0.1% +$158 0.12% 138
2021
Q4
$274K Buy
+3,574
New +$285K 0.11% 139

Other funds holding MRK

Keystone Wealth Services's MRK Position: Q3 2024 in Review

Keystone Wealth Services sold out of Merck (MRK) in Q3 2024, closing a stake of 1,692 shares — an estimated $209K sold.

Keystone Wealth Services first reported a position in MRK in Q4 2021 and held it in 11 quarters. The position peaked at $501K in Q2 2023. 3,489 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

  • Keystone Wealth Services reported no remaining Merck position as of Q3 2024 after selling out during the quarter.
  • Keystone Wealth Services sold 1,692 Merck shares in Q3 2024, an estimated $209K.
  • Keystone Wealth Services first reported a position in Merck in Q4 2021 and held it in 11 quarters.
  • Keystone Wealth Services's Merck position peaked at $501K in Q2 2023.
  • 3,489 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on Keystone Wealth Services's 13F filing for Q3 2024, filed 15 Oct 2024.